Karo Pharma AB diskutieren
Karo Pharma AB
WKN: A14YW4 / Symbol: KARO / Name: Karo Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
5,44 €
-0,18 %
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $27.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $37.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Raymond James from $30.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $26.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $34.00 to $31.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $31.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Morgan Stanley from $31.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $51.00 price target on the stock, up previously from $46.00.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $51.00 to $58.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Morgan Stanley from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $60.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for KARO provided by MarketBeat
Neueste Beiträge
StockNews_com in Citi Trends Inc. diskutieren